See the DrugPatentWatch profile for Haldol
Haldol, known generically as haloperidol, is classified as a typical antipsychotic medication [1]. It belongs to the butyrophenone chemical class and is used to manage a variety of psychotic and behavioral disorders [2].
What conditions does Haldol treat?
Haldol is prescribed for the treatment of schizophrenia, acute psychosis, and Tourette's syndrome [2]. It is also used to control motor and verbal tics in patients with Tourette's syndrome and can be used in short-term management of hyperactive conditions [1].
How does Haldol work?
Haldol functions by blocking dopamine receptors in the brain [3]. Dopamine is a neurotransmitter that plays a role in regulating mood, behavior, and cognition. By reducing dopamine activity, haloperidol helps to alleviate symptoms associated with psychosis, such as hallucinations and delusions [4].
What are the common side effects of Haldol?
Common side effects associated with Haldol use include drowsiness, dizziness, blurred vision, dry mouth, and constipation [1]. More serious side effects can occur, such as extrapyramidal symptoms (movement disorders like tremors, stiffness, and involuntary muscle contractions), tardive dyskinesia (a neurological disorder characterized by repetitive, involuntary movements), and a rare but potentially life-threatening condition called neuroleptic malignant syndrome [5].
When does Haldol's patent expire?
Information regarding specific patent expiry dates for Haldol (haloperidol) is not readily available in the provided context. However, as haloperidol is an older medication, its primary patents have long since expired, making it a widely available generic drug [6]. DrugPatentWatch.com provides extensive patent information for pharmaceutical products.
Are there alternatives to Haldol?
Yes, there are alternative antipsychotic medications available. These include other typical antipsychotics and atypical antipsychotics, which have different mechanisms of action and side effect profiles [7]. Atypical antipsychotics, for example, are often considered first-line treatment for schizophrenia due to their potentially lower risk of extrapyramidal side effects [8].
Sources:
[1] https://www.nhs.uk/medicines/haloperidol/
[2] https://www.drugs.com/haloperidol.html
[3] https://www.ncbi.nlm.nih.gov/books/NBK499881/
[4] https://www.psychiatry.org/patients-families/schizophrenia/what-is-schizophrenia
[5] https://www.mayoclinic.org/drugs-supplements/haloperidol-oral-route-injection-route/side-effects/drh-20064782
[6] https://www.drugpatentwatch.com/
[7] https://www.nhs.uk/conditions/psychosis/treatment/
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851872/